Ardelyx (ARDX) Current Deferred Revenue (2013 - 2026)
Ardelyx (ARDX) reported Current Deferred Revenue of $3.2 million for Q1 2026, down 70.24% on a YoY basis from $10.9 million in Q1 2025, and up 169.32% quarter-over-quarter from $1.2 million in Q4 2025.
Ardelyx (ARDX) Current Deferred Revenue (2013 - 2026) Analysis & Trends
Ardelyx has reported Current Deferred Revenue for 12 years, with the latest figure at $3.2 million in Q1 2026.
- For the quarter ending Q1 2026, Current Deferred Revenue fell 70.24% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (down 70.24% YoY), and the FY2025 full-year result was $1.2 million, down 88.71% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $3.2 million, up from $1.2 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $10.9 million in Q1 2025, with the low at $1.2 million in Q4 2025.
- Historically, Current Deferred Revenue has averaged $6.5 million across 5 years, with a median of $6.4 million in 2025.
- Annual changes were most pronounced in 2022 — Current Deferred Revenue jumped 659.58% — and 2025, when it tumbled 88.71%.
- Ardelyx's Current Deferred Revenue stood at $4.2 million in 2022, then surged by 70.55% to $7.2 million in 2023, then soared by 48.79% to $10.7 million in 2024, then plunged by 88.71% to $1.2 million in 2025, then surged by 169.32% to $3.2 million in 2026.
- The last three Current Deferred Revenue figures came in at $3.2 million (Q1 2026), $1.2 million (Q4 2025), and $6.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.25 Mn |
| Dec 31, 2025 | 1.21 Mn |
| Sep 30, 2025 | 6.58 Mn |
| Jun 30, 2025 | 6.28 Mn |
| Mar 31, 2025 | 10.91 Mn |
| Dec 31, 2024 | 10.69 Mn |
| Sep 30, 2024 | 7.27 Mn |
| Jun 30, 2024 | 10.83 Mn |
| Mar 31, 2024 | 6.59 Mn |
| Dec 31, 2023 | 7.18 Mn |
| Sep 30, 2023 | 4.07 Mn |
| Jun 30, 2023 | 5.96 Mn |
| Mar 31, 2023 | 5.55 Mn |
| Dec 31, 2022 | 4.21 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Jun 30, 2022 | 10.00 Mn |
| Sep 30, 2021 | 527,000.00 |
| Jun 30, 2021 | 1.41 Mn |
| Mar 31, 2021 | 2.72 Mn |
| Dec 31, 2020 | 4.18 Mn |